Literature DB >> 17145696

Metabolism of capsaicinoids by P450 enzymes: a review of recent findings on reaction mechanisms, bio-activation, and detoxification processes.

Christopher A Reilly1, Garold S Yost.   

Abstract

Capsaicinoids are botanical irritants present in chili peppers. Chili pepper extracts and capsaicinoids are common dietary constituents and important pharmaceutical agents. Use of these substances in modern consumer products and medicinal preparations occurs worldwide. Capsaicinoids are the principals of pepper spray self-defense weapons and several over-the-counter pain treatments as well as the active component of many dietary supplements. Capsaicinoids interact with the capsaicin receptor (a.k.a., VR1 or TRPV1) to produce acute pain and cough as well as long-term analgesia. Capsaicinoids are also toxic to many cells via TRPV1-dependent and independent mechanisms. Chemical modifications to capsaicinoids by P450 enzymes decreases their potency at TRPV1 and reduces the pharmacological and toxicological phenomena associated with TRPV1 stimulation. Metabolism of capsaicinoids by P450 enzymes also produces reactive electrophiles capable of modifying biological macromolecules. This review highlights data describing specific mechanisms by which P450 enzymes convert the capsaicinoids to novel products and explores the relationship between capsaicinoid metabolism and its effects on capsaicinoid pharmacology and toxicology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17145696      PMCID: PMC2390586          DOI: 10.1080/03602530600959557

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  78 in total

Review 1.  Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes.

Authors:  Bernard Meunier; Samuël P de Visser; Sason Shaik
Journal:  Chem Rev       Date:  2004-09       Impact factor: 60.622

2.  Acute toxicity of capsaicin in several animal species.

Authors:  T Glinsukon; V Stitmunnaithum; C Toskulkao; T Buranawuti; V Tangkrisanavinont
Journal:  Toxicon       Date:  1980       Impact factor: 3.033

3.  Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells.

Authors:  Christopher A Reilly; William J Ehlhardt; David A Jackson; Palaniappan Kulanthaivel; Abdul E Mutlib; Robert J Espina; David E Moody; Dennis J Crouch; Garold S Yost
Journal:  Chem Res Toxicol       Date:  2003-03       Impact factor: 3.739

4.  Capsaicin pepper, cancer and ethnicity.

Authors:  Victor E Archer; Daniel W Jones
Journal:  Med Hypotheses       Date:  2002-10       Impact factor: 1.538

5.  CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids.

Authors:  Samuel S Chuang; Christian Helvig; Mohammed Taimi; Heather A Ramshaw; Andrew H Collop; Ma'an Amad; Jay A White; Martin Petkovich; Glenville Jones; Bozena Korczak
Journal:  J Biol Chem       Date:  2003-12-03       Impact factor: 5.157

6.  Capsaicinoids cause inflammation and epithelial cell death through activation of vanilloid receptors.

Authors:  Christopher A Reilly; Jack L Taylor; Diane L Lanza; Brian A Carr; Dennis J Crouch; Garold S Yost
Journal:  Toxicol Sci       Date:  2003-05       Impact factor: 4.849

7.  TRPV1 receptors mediate particulate matter-induced apoptosis.

Authors:  N Agopyan; J Head; S Yu; S A Simon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-11-21       Impact factor: 5.464

8.  Oxygen economy of cytochrome P450: what is the origin of the mixed functionality as a dehydrogenase-oxidase enzyme compared with its normal function?

Authors:  Devesh Kumar; Samuël P De Visser; Sason Shaik
Journal:  J Am Chem Soc       Date:  2004-04-28       Impact factor: 15.419

9.  Interaction of capsaicinoids with drug-metabolizing systems. Relationship to toxicity.

Authors:  M S Miller; K Brendel; T F Burks; I G Sipes
Journal:  Biochem Pharmacol       Date:  1983-02-01       Impact factor: 5.858

10.  Molecular determinants of vanilloid sensitivity in TRPV1.

Authors:  Narender R Gavva; Lana Klionsky; Yusheng Qu; Licheng Shi; Rami Tamir; Steve Edenson; T J Zhang; Vellarkad N Viswanadhan; Attila Toth; Larry V Pearce; Todd W Vanderah; Frank Porreca; Peter M Blumberg; Jack Lile; Yax Sun; Ken Wild; Jean-Claude Louis; James J S Treanor
Journal:  J Biol Chem       Date:  2004-03-02       Impact factor: 5.157

View more
  12 in total

Review 1.  Signaling actions of electrophiles: anti-inflammatory therapeutic candidates.

Authors:  Alison L Groeger; Bruce A Freeman
Journal:  Mol Interv       Date:  2010-02

Review 2.  Unravelling the mystery of capsaicin: a tool to understand and treat pain.

Authors:  Jessica O'Neill; Christina Brock; Anne Estrup Olesen; Trine Andresen; Matias Nilsson; Anthony H Dickenson
Journal:  Pharmacol Rev       Date:  2012-10       Impact factor: 25.468

3.  Reactive intermediates produced from the metabolism of the vanilloid ring of capsaicinoids by p450 enzymes.

Authors:  Christopher A Reilly; Fred Henion; Tim S Bugni; Manivannan Ethirajan; Chris Stockmann; Kartick C Pramanik; Sanjay K Srivastava; Garold S Yost
Journal:  Chem Res Toxicol       Date:  2012-11-06       Impact factor: 3.739

4.  Structure-activity relationship of capsaicin analogs and transient receptor potential vanilloid 1-mediated human lung epithelial cell toxicity.

Authors:  Karen C Thomas; Manivannan Ethirajan; Kiumars Shahrokh; Hao Sun; Jeewoo Lee; Thomas E Cheatham; Garold S Yost; Christopher A Reilly
Journal:  J Pharmacol Exp Ther       Date:  2011-02-22       Impact factor: 4.030

5.  Oxidant-based anticancer activity of a novel synthetic analogue of capsaicin, capsaicin epoxide.

Authors:  Anna Lewinska; Pawel Chochrek; Karolina Smolag; Ewa Rawska; Maciej Wnuk
Journal:  Redox Rep       Date:  2014-11-08       Impact factor: 4.412

6.  CCAAT/ enhancer-binding protein β activation by capsaicin contributes to the regulation of CYP1A1 expression, mediated by the aryl hydrocarbon receptor.

Authors:  Eun Hee Han; Yong Pil Hwang; Hyung Gyun Kim; Jai Ho Choi; Bong Hwan Park; Gye Yong Song; Gye Won Lee; Tae Cheon Jeong; Hye Gwang Jeong
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

7.  Non-vanillyl resiniferatoxin analogues as potent and metabolically stable transient receptor potential vanilloid 1 agonists.

Authors:  Hyun-Kyung Choi; Sun Choi; Yoonji Lee; Dong Wook Kang; HyungChul Ryu; Han-Joo Maeng; Suk-Jae Chung; Vladimir A Pavlyukovets; Larry V Pearce; Attila Toth; Richard Tran; Yun Wang; Matthew A Morgan; Peter M Blumberg; Jeewoo Lee
Journal:  Bioorg Med Chem       Date:  2008-12-25       Impact factor: 3.641

8.  A dynamic interface for capsaicinoid systems biology.

Authors:  Michael Mazourek; Anuradha Pujar; Yelena Borovsky; Ilan Paran; Lukas Mueller; Molly M Jahn
Journal:  Plant Physiol       Date:  2009-06-24       Impact factor: 8.340

9.  Capsaicinoids, chloropicrin and sulfur mustard: possibilities for exposure biomarkers.

Authors:  Maija Pesonen; Kirsi Vähäkangas; Mia Halme; Paula Vanninen; Heikki Seulanto; Matti Hemmilä; Markku Pasanen; Tapio Kuitunen
Journal:  Front Pharmacol       Date:  2010-12-20       Impact factor: 5.810

10.  A framework incorporating the impact of exposure scenarios and application conditions on risk assessment of chemicals applied to skin.

Authors:  Yuri Dancik; John A Troutman; Joanna Jaworska
Journal:  In Silico Pharmacol       Date:  2013-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.